Sign in

CIK 0001429260

  • Non-accelerated filer
  • Smaller reporting company

Fortress Biotech, Inc.

Sign in to watch
Ticker
FBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
205157386
Phone
+1 781-652-4500
Business address
1111 KANE CONCOURSE, SUITE 301, BAY HARBOR ISLANDS, FL, 33154
Former names
Fortress Biotech, Inc., CORONADO BIOSCIENCES INC

Securities

  • FBIO Common Stock Nasdaq
  • FBIOP 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock Nasdaq
  1. 4 Grant or award 10% owner acquired 2,101,496 shares (grant or award)
  2. 4 Grant or award Chief Financial Officer acquired 140,000 shares (grant or award)
  3. 4 Open-market buy President, CEO & Chairman bought 1,567,515 shares at $1.70 ($2,664,776)
  4. 4 Open-market buy See Remarks bought 147,058 shares at $1.70 ($249,999)
  5. 4 Open-market buy President, CEO & Chairman bought 100,000 shares at $0.28 ($28,330)
  6. 4 Insider Changes in Ownership
  7. 4 Open-market buy 10% owner bought 418,410 shares at $0.72 ($301,255)
  8. 4 Open-market buy President, CEO & Chairman bought 20,000 shares at an average $10.55 ($210,900)
  9. 4 Insider Changes in Ownership
  10. 4 Grant or award 10% owner acquired 52,419 shares (grant or award)
  11. 4 Insider Changes in Ownership
  12. 4 Open-market buy See Remarks bought 1,197,604 shares at $0.84 ($999,999)
  13. 4 Open-market buy Director bought 11,976 shares at $0.84 ($10,000)
  14. 4 Open-market buy President, CEO & Chairman bought 2,395,209 shares at $0.84 ($2,000,000)
  15. 4 Open-market buy Director bought 11,976 shares at $0.84 ($10,000)
  16. 4 Open-market buy Director bought 299,401 shares at $0.84 ($250,000)
  17. 4 Open-market buy Chief Financial Officer bought 35,928 shares at $0.84 ($30,000)
  18. 4 Grant or award 10% owner acquired 2,807,008 shares (grant or award)
  19. 4 Insider Changes in Ownership
  20. 4 Grant or award President, CEO & Chairman acquired 1,223,558 shares (grant or award)

Page 4 of 15 · 289 filings